Literature DB >> 8885029

Anticoagulant treatment in primary health care in Finland.

K Eskola1, P Aittoniemi, H Kurunmäki, A Latva-Nevala, M Paloneva, A M Wallin, M Viitaniemi, I Virjo, S Ylinen, S Ohman, M Isokoski.   

Abstract

OBJECTIVE: To establish the prevalence of anticoagulant (AC) treatment, the indications, and the quality of care in primary health care.
DESIGN: A cross-sectional study, in which patients on AC treatment were identified from laboratory records. The main and second indications for AC treatment and the last value of the AC-test were taken from medical records.
SETTING: Eight Finnish health centres with a total population of 182091 inhabitants.
RESULTS: A total of 1255 patients on AC treatment were identified, 48% of them men. The mean age was 68.9 years. The age-adjusted prevalence of AC treatment was 0.65%. The commonest main indication was atrial fibrillation (38%). It was the main or second indication in 591 patients (age-adjusted prevalence 0.30%). The next commonest main indication was deep vein thrombosis (15%), followed by pulmonary embolism (8%). A total of 274 (22%) patients were anticoagulated for cerebral circulatory disturbances. 86% of the latest prothrombin time values fell within recommended ranges.
CONCLUSION: The prevalence of AC treatment in Finland seems to be high. The proportion of patients with atrial fibrillation is high, differing from the results in other countries. The monitoring of AC-treatment as the general practitioner's responsibility functions well. The quality of care is good, even in older age groups.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8885029     DOI: 10.3109/02813439609024172

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  3 in total

1.  Who receives anticoagulant treatment with warfarin and why? A population-based study in Finland.

Authors:  Irma Virjo; Kari Mäkelä; Juhani Aho; Pentti Kalliola; Harri Kurunmäki; Leena Uusitalo; Markku Valli; Suvi Ylinen
Journal:  Scand J Prim Health Care       Date:  2010-09-07       Impact factor: 2.581

2.  Anticoagulant treatment in primary health care in Sweden - prevalence, incidence and treatment diagnosis: a retrospective study on electronic patient records in a registered population.

Authors:  Gunnar H Nilsson; Ingela Björholt; Hans Johnsson
Journal:  BMC Fam Pract       Date:  2003-04-01       Impact factor: 2.497

3.  Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.

Authors:  Gunnar H Nilsson; Ingela Björholt
Journal:  BMC Clin Pharmacol       Date:  2004-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.